Consequently, conditional deletion of Il10 within T cells augments anti-tumor immunity upon Treg cell-depletion in mice, and antibody blockade of IL-10 signaling synergizes with Treg cell depletion to overcome treatment resistance. The gene discussed is IL10; the disease is neoplasm.